Craneware plc Holding(s) in Company (4138Q)
18 Giugno 2020 - 3:37PM
UK Regulatory
TIDMCRW
RNS Number : 4138Q
Craneware plc
18 June 2020
Craneware plc
("Craneware" or the "Company")
Holdings in the Company
18 June 2020 - The Board of Craneware plc (AIM: CRW.L), the
market leader in Value Cycle software solutions for the US
healthcare market, has been notified that Derek Paterson, CIO of
the Company, has today transferred 265,100 ordinary shares of 1p
each in the Company ("Ordinary Shares") to members of his family,
as part of his estate planning. The holdings shall be subject to
certain lock-in arrangements.
Subsequent to this transaction, Mr. Paterson holds 622,872
Ordinary Shares in the Company, representing 2.3% of the issued
share capital.
NOTIFICATION OF MAJOR HOLDINGS
1a. Identity of the issuer or CRANEWARE PLC
the underlying issuer of existing
shares to which voting rights
are attached (ii) :
--------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark
with an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box
or boxes with an "X")
An acquisition or disposal of voting rights x
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify)(iii) :
----
3. Details of person subject to the notification obligation (iv)
Name DEREK PATERSON
City and country of registered N/A
office (if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name N/A
--------------------------------------------
City and country of registered N/A
office (if applicable)
--------------------------------------------
5. Date on which the threshold 18/6/2020
was crossed or reached (vi) :
--------------------------------------------
6. Date on which issuer notified 18/6/2020
(DD/MM/YYYY):
--------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ --------------------- -------------- --------------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 2.3% N/A 2.3% 26,826,539
------------------ --------------------- -------------- --------------------
Position
of previous
notification
(if
applicable) 3.4% N/A 3.4% 24,929,950
------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) of Directive
(DTR5.1) (DTR5.2.1) 2004/109/EC)
(DTR5.2.1)
--------------------------
GB00B2425G68 622,872 N/A 2.3% N/A
------------------------- -------------------------- ------------------------- --------------
SUBTOTAL 8. A 622,872 2.3%
----------------------------------------------------- -----------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive
2004/109/EC (DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
(x) (xi) be acquired if
the instrument
is
exercised/converted.
-------------- ------------------------------ -------------------------------- --------------
SUBTOTAL 8. B 1
------------------------------ -------------------------------- --------------
B 2: Financial Instruments with similar economic effect according
to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting
financial date (x) Conversion cash voting rights rights
instrument Period (xi) settlement
(xii)
------------------- -------------------- -------------------- --------------------
SUBTOTAL 8.B.2
-------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled X
by any natural person or legal entity and does not control
any other undertaking(s) holding directly or indirectly an
interest in the (underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting
rights and/or the
financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity (xiv) (please
add additional rows as necessary)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is higher
is higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
---------------------- --------------------- --------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder N/A
-------------------------------------------------
The number and % of voting rights N/A
held
-------------------------------------------------
The date until which the voting N/A
rights will be held
-------------------------------------------------
11. Additional information (xvi)
Disposal is a transfer (including voting rights) to members of family
under a "Deed of Gift"
Place of completion Edinburgh, Scotland
Date of completion 18/6/2020
--------------------
For further information, please contact:
Craneware plc Peel Hunt (NOMAD & Investec Bank (Joint Alma (Financial
Joint Broker) Broker) PR)
+44 (0)131 550 +44 (0)203 405
3100 +44 (0)20 7418 8900 +44 (0)20 7597 5970 0205
Keith Neilson, Dan Webster Patrick Robb Caroline Forde
CEO
Craig Preston, George Sellar Sebastian Lawrence Helena Bogle
CFO
Andrew Clark Henry Reast
About Craneware
Craneware (AIM: CRW.L), the leader in automated value cycle
solutions, collaborates with U.S. healthcare providers to plan,
execute and monitor value-based economic performance. Founded in
1999, Craneware is headquartered in Edinburgh, Scotland with
offices in Atlanta and Pittsburgh employing over 350 staff.
Craneware's value cycle management suite includes charge capture,
strategic pricing, patient engagement, claims analytics, revenue
recovery and retention, and cost and margin intelligence
solutions.
Learn more at www.craneware.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLFLFVVRRITLII
(END) Dow Jones Newswires
June 18, 2020 09:37 ET (13:37 GMT)
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024
